Once again, stocks have delivered an upset. Despite the havoc wreaked by COVID-19 during the second quarter, corporate profits have generally been better-than-expected.
Are penny stocks a must-have or a must-avoid? Well, that depends on who you ask.
The stock market just keeps going up, up and away. COVID-19 continues to have a choke hold on the economy, yet stocks have …
The “dog days” of summer are here, but it’s just as busy as ever on the Street. As earnings results continue to roll …
The stock market has been holding up remarkably well, but why? Against the backdrop of weak second quarter earnings results, investors are piling …
In this time of pandemic, stock markets have mostly been – rising. Yes, we had a crash in February/March, part of that initial …
Despite COVID-19’s devastating impact on the economy, Oppenheimer’s Chief Investment Strategist John Stoltzfus remains overweight on U.S.
Which stocks have been the stars of 2020? Biotechs.
Shares of Atossa Therapeutics (ATOS) have done what shares of most companies in the hunt for coronavirus solutions have done in 2020 – …
The healthcare sector took its place among the winners this year, rising 21%, compared to the S&P 500’s 0.5% growth.
